Mary Beth David

Mary Beth David is an accomplished professional in the field of dermatology sales, currently serving as an Executive Clinical Account Specialist at UCB since January 2021. Prior experience includes roles as a Senior Clinical Account Specialist at Novartis from February 2015 to January 2021, where significant contributions were made in promoting the first-in-class injectable biologic Cosentyx for plaque psoriasis and psoriatic arthritis. Mary Beth's career began at Stiefel, a GSK company, and includes extensive roles at Galderma and inVentiv Health, demonstrating a strong track record of sales achievement, new product launches, and leadership in strategizing and executing successful marketing initiatives. Mary Beth holds a Bachelor's Degree in Management with a minor in Marketing from the University of Massachusetts Boston.